Wednesday 25 December 2024

The Pharma Letter Podcast — Episode 8 — Why hasn't the world embraced Sputnik V?

Biotechnology
Simon Wentworth
14 December 2021
kirill_dmitriev_rdif_podcast

More on this story...

Pharmaceutical
RDIF announces interim results of 1,000 participant Argentinian study into Sputnik Light
15 October 2021
Pharmaceutical
RDIF and Serum Institute agree manufacturing deal for Sputnik V
13 July 2021
Pharmaceutical
RDIF and UNICEF sign Sputnik V vaccine supply deal
27 May 2021
Pharmaceutical
Sputnik V better than Comirnaty against Omicron, study says
20 January 2022


Companies featured in this story

More ones to watch >


Today's issue

AstraZeneca withdraws EU submission for lung cancer drug
Biotechnology
AstraZeneca withdraws EU submission for lung cancer drug
24 December 2024
Biotechnology
Valneva links up with SII for chikungunya vaccine in Asia
24 December 2024
Generics
Viatris faces FDA import restrictions at Indian facility
24 December 2024
Pharmaceutical
Aficamten attracts more interest as Sanofi buys China rights
24 December 2024
Biotechnology
Positive Phase III trials results with BMS’ Sotyktu
24 December 2024
Generics
FDA approves first generic of Victoza
24 December 2024
Pharmaceutical
Sumitomo gains FDA approval of Gemtesa for OAB
24 December 2024

Company Spotlight

A clinical-stage immuno-oncology company from Switzerland.




More Features in Biotechnology

AstraZeneca withdraws EU submission for lung cancer drug
24 December 2024
Valneva links up with SII for chikungunya vaccine in Asia
24 December 2024
Positive Phase III trials results with BMS’ Sotyktu
24 December 2024
RAPT obtains worldwide rights ex-China to Jemincare MAb
24 December 2024


Copyright © The Pharma Letter 2024   |   Headless Content Management with Blaze